Download PDF
HeartFlow's Transformation of Heart Disease Diagnosis and Treatment with AWS
Technology Category
- Analytics & Modeling - Machine Learning
- Cybersecurity & Privacy - Security Compliance
Applicable Industries
- Education
- Healthcare & Hospitals
Applicable Functions
- Product Research & Development
- Quality Assurance
Use Cases
- Automated Disease Diagnosis
- Disease Tracking
Services
- Cloud Planning, Design & Implementation Services
- Testing & Certification
The Challenge
HeartFlow, a medical technology company, is revolutionizing the diagnosis and treatment of heart disease with its non-invasive HeartFlow FFRct Analysis. This technology uses deep learning to create a personalized 3D model of the heart, allowing clinicians to better evaluate the impact of a blockage on blood flow and determine the best treatment. However, the company faced a significant challenge. Cardiovascular disease, the world’s leading cause of death, claims more than 17 million lives each year. The most common type, coronary artery disease (CAD), reduces blood flow to the heart, causing chest pain, heart attack, and death. Clinicians need to know if and where there is a blockage, and how it is affecting blood flow. This information is crucial in choosing the best treatment pathway for the patient, such as medical management, stenting or bypass surgery. However, the diagnostic coronary angiogram often used to detect CAD is invasive, expensive, and potentially risky. More than half of patients who undergo the test have no significant blockages, and the procedure can be associated with serious complications.
About The Customer
HeartFlow is a medical technology company that is redefining the way heart disease is diagnosed and treated. The company has developed a non-invasive technology, the HeartFlow FFRct Analysis, which uses deep learning to create a personalized 3D model of the heart. This model allows clinicians to better evaluate the impact of a blockage on blood flow and determine the best treatment for the patient. HeartFlow's technology is designed to help clinicians diagnose and treat patients with suspected coronary artery disease (CAD), the most common type of heart disease and the world's leading cause of death. The company's mission is to improve heart care worldwide by providing a safer, more effective alternative to the invasive, expensive, and potentially risky diagnostic coronary angiogram often used to detect CAD.
The Solution
HeartFlow developed the HeartFlow FFRct Analysis, a non-invasive technology that helps clinicians diagnose and treat patients with suspected CAD. It provides clinicians with insight into the extent of CAD and its effect on blood flow, helping them design a definitive, personalized treatment plan for each patient and reduce additional testing. Data from a non-invasive coronary CT angiogram is securely uploaded from the hospital to the cloud. HeartFlow uses deep learning to create a personalized, digital 3D model of the patient’s coronary arteries. HeartFlow’s certified analysts make any necessary corrections to the model. Then, the HeartFlow Analysis uses machine learning and computational fluid dynamics (CFD) algorithms to solve millions of equations regarding the blood flow. The resulting HeartFlow FFRct Analysis shows how blockages are affecting coronary blood flow and is provided to the healthcare team via a secure web interface. To meet the massive processing power required for timely results, HeartFlow transitioned its entire infrastructure to Amazon Web Services (AWS).
Operational Impact
Quantitative Benefit
Related Case Studies.
Case Study
Hospital Inventory Management
The hospital supply chain team is responsible for ensuring that the right medical supplies are readily available to clinicians when and where needed, and to do so in the most efficient manner possible. However, many of the systems and processes in use at the cancer center for supply chain management were not best suited to support these goals. Barcoding technology, a commonly used method for inventory management of medical supplies, is labor intensive, time consuming, does not provide real-time visibility into inventory levels and can be prone to error. Consequently, the lack of accurate and real-time visibility into inventory levels across multiple supply rooms in multiple hospital facilities creates additional inefficiency in the system causing over-ordering, hoarding, and wasted supplies. Other sources of waste and cost were also identified as candidates for improvement. Existing systems and processes did not provide adequate security for high-cost inventory within the hospital, which was another driver of cost. A lack of visibility into expiration dates for supplies resulted in supplies being wasted due to past expiry dates. Storage of supplies was also a key consideration given the location of the cancer center’s facilities in a dense urban setting, where space is always at a premium. In order to address the challenges outlined above, the hospital sought a solution that would provide real-time inventory information with high levels of accuracy, reduce the level of manual effort required and enable data driven decision making to ensure that the right supplies were readily available to clinicians in the right location at the right time.
Case Study
Gas Pipeline Monitoring System for Hospitals
This system integrator focuses on providing centralized gas pipeline monitoring systems for hospitals. The service they provide makes it possible for hospitals to reduce both maintenance and labor costs. Since hospitals may not have an existing network suitable for this type of system, GPRS communication provides an easy and ready-to-use solution for remote, distributed monitoring systems System Requirements - GPRS communication - Seamless connection with SCADA software - Simple, front-end control capability - Expandable I/O channels - Combine AI, DI, and DO channels
Case Study
Driving Digital Transformations for Vitro Diagnostic Medical Devices
Diagnostic devices play a vital role in helping to improve healthcare delivery. In fact, an estimated 60 percent of the world’s medical decisions are made with support from in vitrodiagnostics (IVD) solutions, such as those provided by Roche Diagnostics, an industry leader. As the demand for medical diagnostic services grows rapidly in hospitals and clinics across China, so does the market for IVD solutions. In addition, the typically high cost of these diagnostic devices means that comprehensive post-sales services are needed. Wanteed to improve three portions of thr IVD:1. Remotely monitor and manage IVD devices as fixed assets.2. Optimizing device availability with predictive maintenance.3. Recommending the best IVD solution for a customer’s needs.
Case Study
HaemoCloud Global Blood Management System
1) Deliver a connected digital product system to protect and increase the differentiated value of Haemonetics blood and plasma solutions. 2) Improve patient outcomes by increasing the efficiency of blood supply flows. 3) Navigate and satisfy a complex web of global regulatory compliance requirements. 4) Reduce costly and labor-intensive maintenance procedures.
Case Study
Harnessing real-time data to give a holistic picture of patient health
Every day, vast quantities of data are collected about patients as they pass through health service organizations—from operational data such as treatment history and medications to physiological data captured by medical devices. The insights hidden within this treasure trove of data can be used to support more personalized treatments, more accurate diagnosis and more advanced preparative care. But since the information is generated faster than most organizations can consume it, unlocking the power of this big data can be a struggle. This type of predictive approach not only improves patient care—it also helps to reduce costs, because in the healthcare industry, prevention is almost always more cost-effective than treatment. However, collecting, analyzing and presenting these data-streams in a way that clinicians can easily understand can pose a significant technical challenge.